O T C
PAOG Targets International Segment Of $5 Billion CBD Nutraceutical Market

  Sandusky, OH, May 13, 2021 –  OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion

PAOG Confirms CBD Nutraceutical Q4 Revenue Plans

  Sandusky, OH, May 11, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021. On Friday, PAOG released a preview of the company’s plan to launch a CBD Nutraceuticals line of products.  PAOG’s CBD

PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday

  Sandusky, OH, May 5, 2021 – OTC PR WIRE — PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived

PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

  Sandusky, OH, May 3, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive

PAOG Anticipates Boost To CBD Pharmaceutical Research Initiative From Improving Cannabis Legalization Outlook

  Sandusky, OH, April 28, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG’s ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in

PAOG Advances CBD Pharmaceutical Developments Backed By US Patent

  Sandusky, OH, April 8, 2021 – OTC PR WIRE —  PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is

PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update

  Sandusky, OH, March 10, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with

PAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment Market

  Sandusky, OH, March 8, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and depression treatment market anticipated to reach a value of $18 billion by 2025. The company recently announced plans to produce a variety of nutraceuticals

PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals

  Sandusky, OH, February 18, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted the company’s anticipated revenue expected this year from its CBD nutraceutical expansion.  Earlier this week, the company published an online, multimedia presentation detailing the company’s CBD nutraceutical development expansion plans.  The presentation includes details on PAOG’s

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

Sandusky, OH, February 16, 2021 –  OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today published an online, multimedia presentation detailing the company’s CBD nutraceutical development expansion plans. The CBD nutraceutical development expansion plans are anticipated to generate revenue beginning this year, in 2021 adding to the company’s previously announced anticipated revenue for

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019